Valuation check: SEPN's profit margin is -24.51%, below the Healthcare sector average of 13.76%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for SEPN is -24.51% as of June 2026. That compares with -12053.03% in the prior-year period — up 99.8% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside Septerna's historical trend and sector peers before judging valuation or financial health.
Over the past year, SEPN's profit margin moved from -12053.03% to -24.51% — a 99.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Septerna's valuation or profitability profile.
Against Healthcare companies, SEPN currently prints -24.51% for profit margin, while the sector average sits near 13.76%. That is roughly 278.1% below the sector mean. Large gaps often invite a closer look at Septerna's growth, margins, and balance sheet.
Profit Margin shows how effectively Septerna converts resources into returns. At -24.51%, SEPN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -12053.03% in the prior-year period — up 99.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SEPN's profit margin (-24.51%), review year-over-year change from -12053.03%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.